2.33
price down icon7.91%   -0.20
after-market Dopo l'orario di chiusura: 2.35 0.02 +0.86%
loading

Alzamend Neuro Inc Azioni (ALZN) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-04-30 2025-01-31 2024-10-31 2024-07-31 2024-04-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
9.79%
1.1389
1.0374 1.3581 0.9624 0.8501
Interest Income/Expense
74.79%
0.000509
0.00202 0.0035 0.012 0.00147
Operating Income/Loss
9.79%
-1.1389
-1.0374 -1.3581 -0.9624 -0.8501
Nonoperating Income/Loss
74.79%
-0.000509
-0.00202 -0.0035 -0.012 -0.00147
Income/Loss From Continuing Operations Before Tax
9.62%
-1.1394
-1.0394 -1.3616 1.00 -19.05
Income/Loss From Continuing Operations After Tax
9.62%
-1.1394
-1.0394 -1.3616 1.00 -19.05
Net Income/Loss
857.66%
7.8754
-1.0394 -1.3616 1.00 0.80
Preferred Stock Dividends And Other Adjustments
0.5902
- - - -
Attributable To Noncontrolling Interest
9.0149
- 0.0537 1.9744 1.6515
Basic Average Shares
151.20%
-2.825
5.5178 3.5317 0.7778 -6.0504
Diluted Average Shares
151.20%
-2.825
5.5178 3.5317 0.7778 -6.0504
Basic Earnings Per Share
5,316%
-10.29
-0.19 -0.40 -1.25 -13.35
Diluted Earnings Per Share
5,316%
-10.29
-0.19 -0.40 -1.25 -13.35
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
0.5902
- - - -
$84.75
price down icon 0.74%
$22.65
price down icon 2.96%
$31.85
price down icon 2.72%
$104.48
price down icon 1.69%
$164.40
price up icon 1.60%
biotechnology ONC
$335.80
price down icon 4.36%
Capitalizzazione:     |  Volume (24 ore):